We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract Symptoms

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00870376
Recruitment Status : Withdrawn (no budget)
First Posted : March 27, 2009
Last Update Posted : February 10, 2017
Sponsor:
Information provided by (Responsible Party):
Sheng-Mou Hsiao, Far Eastern Memorial Hospital

Brief Summary:
Urodynamic study is an objective method to evaluate female patients with lower urinary tract symptoms (LUTS). However, this method includes place a urinary catheter, thus prevents it as a routine method to evaluate and follow up patients with LUTS. Therefore, it is necessary to find a simple and objective method to help in evaluating female patients with LUTS. Several kinds of biomarker had been reported in diagnosing patients with overactive bladder; however, the sensitivity remained poor. The aim of this study is to find a useful biomarker, biomarkers, or combinations, with the aid of urodynamic study, to objectively and precisely in evaluating the female patients with LUTS.

Condition or disease Intervention/treatment
Lower Urinary Tract Symptoms Other: biomarkers

Study Type : Observational
Actual Enrollment : 0 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Studies of Biomarkers in Different Urodynamic Diagnoses of Female Patients With Lower Urinary Tract Symptoms
Actual Study Start Date : April 2009
Primary Completion Date : April 2009
Study Completion Date : April 23, 2009

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Group/Cohort Intervention/treatment
urodynamic studies Other: biomarkers
To define a biomarker or combination of overactive bladder syndrome



Primary Outcome Measures :
  1. The aim of this study is to find a useful biomarker, biomarkers, or combinations, with the aid of urodynamic study, to objectively and precisely in evaluating the female patients with LUTS. [ Time Frame: 3 years ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 99 Years   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
female patients with LUTS
Criteria

Inclusion Criteria:

  • All female patients (> 20 years) with Lower urinary tract syndrome.

Exclusion Criteria:

  • Female patients with tumor and stone were excluded.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00870376


Locations
Taiwan
Department of Obstetrics and Gynecology, Far-Eastern Memorial Hospital
Banciao, Taipei, Taiwan, 22050
Sponsors and Collaborators
Far Eastern Memorial Hospital

Responsible Party: Sheng-Mou Hsiao, Chief, Department of Obstetrics & Gynecology, Far Eastern Memorial Hospital
ClinicalTrials.gov Identifier: NCT00870376     History of Changes
Other Study ID Numbers: 97109
First Posted: March 27, 2009    Key Record Dates
Last Update Posted: February 10, 2017
Last Verified: July 2015

Keywords provided by Sheng-Mou Hsiao, Far Eastern Memorial Hospital:
lower urinary tract symptoms
biomarkers
urodynamic studies

Additional relevant MeSH terms:
Lower Urinary Tract Symptoms
Urological Manifestations
Signs and Symptoms